 Tami Bang
Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 7 | 2022 | 2436 | 0.760 |
Why?
| | Lung Diseases | 3 | 2021 | 718 | 0.660 |
Why?
| | Common Variable Immunodeficiency | 1 | 2018 | 27 | 0.660 |
Why?
| | Radiology Information Systems | 2 | 2017 | 31 | 0.600 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 968 | 0.560 |
Why?
| | Algorithms | 3 | 2016 | 1541 | 0.550 |
Why?
| | Societies, Medical | 4 | 2023 | 703 | 0.510 |
Why?
| | Radiology | 2 | 2017 | 199 | 0.480 |
Why?
| | Catheters | 1 | 2013 | 61 | 0.440 |
Why?
| | Lung Diseases, Interstitial | 3 | 2023 | 464 | 0.430 |
Why?
| | Checklist | 1 | 2013 | 81 | 0.420 |
Why?
| | Medical Errors | 1 | 2013 | 89 | 0.420 |
Why?
| | Lung Neoplasms | 2 | 2022 | 2220 | 0.410 |
Why?
| | Contrast Media | 2 | 2015 | 373 | 0.400 |
Why?
| | Academic Medical Centers | 1 | 2013 | 422 | 0.370 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2013 | 245 | 0.370 |
Why?
| | Aortic Diseases | 2 | 2022 | 94 | 0.350 |
Why?
| | Critical Care | 1 | 2013 | 492 | 0.330 |
Why?
| | Intensive Care Units | 1 | 2013 | 635 | 0.330 |
Why?
| | Diagnostic Imaging | 4 | 2023 | 294 | 0.310 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2023 | 451 | 0.280 |
Why?
| | Electronic Health Records | 1 | 2013 | 829 | 0.270 |
Why?
| | Diaphragm | 1 | 2023 | 36 | 0.230 |
Why?
| | Response Evaluation Criteria in Solid Tumors | 1 | 2022 | 15 | 0.220 |
Why?
| | Oncogenes | 1 | 2022 | 111 | 0.210 |
Why?
| | Thoracic Wall | 1 | 2021 | 14 | 0.210 |
Why?
| | Coronary Vessels | 2 | 2021 | 233 | 0.210 |
Why?
| | Robotic Surgical Procedures | 1 | 2023 | 89 | 0.200 |
Why?
| | Marfan Syndrome | 1 | 2021 | 42 | 0.200 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2021 | 59 | 0.190 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2021 | 71 | 0.190 |
Why?
| | Mucin-5B | 1 | 2022 | 175 | 0.180 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2020 | 83 | 0.180 |
Why?
| | Cardiovascular Abnormalities | 1 | 2019 | 12 | 0.170 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2021 | 181 | 0.170 |
Why?
| | Magnetic Resonance Imaging | 3 | 2021 | 3174 | 0.170 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2022 | 407 | 0.170 |
Why?
| | Proto-Oncogene Proteins | 1 | 2022 | 618 | 0.170 |
Why?
| | Turner Syndrome | 1 | 2019 | 50 | 0.170 |
Why?
| | Hematoma | 1 | 2018 | 51 | 0.170 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2018 | 18 | 0.160 |
Why?
| | Thorax | 1 | 2018 | 45 | 0.160 |
Why?
| | Humans | 27 | 2023 | 118974 | 0.160 |
Why?
| | Radiography, Thoracic | 1 | 2018 | 164 | 0.150 |
Why?
| | Radiology Department, Hospital | 1 | 2017 | 18 | 0.150 |
Why?
| | Foreign Bodies | 1 | 2018 | 98 | 0.150 |
Why?
| | Prostheses and Implants | 1 | 2018 | 141 | 0.150 |
Why?
| | Pregnancy, Abdominal | 1 | 2016 | 3 | 0.140 |
Why?
| | Protein Kinase Inhibitors | 1 | 2022 | 811 | 0.140 |
Why?
| | Simulation Training | 1 | 2017 | 66 | 0.140 |
Why?
| | Inservice Training | 1 | 2017 | 106 | 0.140 |
Why?
| | Personnel Selection | 1 | 2017 | 71 | 0.140 |
Why?
| | Fasciola hepatica | 1 | 2015 | 4 | 0.140 |
Why?
| | Fascioliasis | 1 | 2015 | 6 | 0.140 |
Why?
| | User-Computer Interface | 2 | 2006 | 163 | 0.130 |
Why?
| | Methotrexate | 1 | 2016 | 227 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 499 | 0.130 |
Why?
| | Education, Medical, Undergraduate | 1 | 2017 | 199 | 0.130 |
Why?
| | Piperazines | 1 | 2017 | 316 | 0.120 |
Why?
| | Prostate | 1 | 2015 | 158 | 0.120 |
Why?
| | Faculty, Medical | 1 | 2017 | 252 | 0.120 |
Why?
| | Aorta | 3 | 2022 | 367 | 0.120 |
Why?
| | Pancreatic Neoplasms | 1 | 2021 | 734 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1597 | 0.120 |
Why?
| | Arthritis, Rheumatoid | 1 | 2022 | 989 | 0.120 |
Why?
| | Gait | 2 | 2006 | 253 | 0.110 |
Why?
| | Colorado | 2 | 2013 | 4196 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 1 | 2022 | 2275 | 0.110 |
Why?
| | Myocardial Infarction | 1 | 2020 | 968 | 0.110 |
Why?
| | Chronic Disease | 1 | 2018 | 1636 | 0.110 |
Why?
| | Pulmonary Artery | 1 | 2018 | 1063 | 0.110 |
Why?
| | Walking | 2 | 2006 | 415 | 0.100 |
Why?
| | Dyspnea | 2 | 2023 | 201 | 0.100 |
Why?
| | Heart Defects, Congenital | 1 | 2018 | 703 | 0.100 |
Why?
| | Computer Simulation | 2 | 2006 | 922 | 0.100 |
Why?
| | Iliac Vein | 1 | 2010 | 9 | 0.090 |
Why?
| | Iliac Artery | 1 | 2010 | 44 | 0.090 |
Why?
| | Lung | 2 | 2023 | 3664 | 0.090 |
Why?
| | Peripheral Vascular Diseases | 1 | 2010 | 98 | 0.090 |
Why?
| | Venous Thrombosis | 1 | 2010 | 147 | 0.080 |
Why?
| | United States | 5 | 2023 | 12555 | 0.080 |
Why?
| | Evidence-Based Medicine | 2 | 2021 | 693 | 0.080 |
Why?
| | Liver | 1 | 2015 | 1816 | 0.080 |
Why?
| | Syndrome | 2 | 2022 | 344 | 0.070 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 1974 | 0.070 |
Why?
| | Visual Perception | 1 | 2006 | 141 | 0.070 |
Why?
| | Female | 11 | 2023 | 61565 | 0.070 |
Why?
| | Ultrasonography | 2 | 2021 | 716 | 0.060 |
Why?
| | Kidney Failure, Chronic | 1 | 2010 | 516 | 0.060 |
Why?
| | Middle Aged | 6 | 2023 | 27617 | 0.060 |
Why?
| | Incidence | 2 | 2023 | 2424 | 0.060 |
Why?
| | Kidney Transplantation | 1 | 2010 | 585 | 0.060 |
Why?
| | Male | 9 | 2023 | 57801 | 0.060 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2021 | 16 | 0.050 |
Why?
| | Adult | 6 | 2023 | 31512 | 0.050 |
Why?
| | Chest Pain | 1 | 2021 | 84 | 0.050 |
Why?
| | Fatigue | 1 | 2023 | 297 | 0.050 |
Why?
| | Patient Reported Outcome Measures | 1 | 2023 | 252 | 0.050 |
Why?
| | Genetic Markers | 1 | 2022 | 348 | 0.050 |
Why?
| | Blood Vessel Prosthesis | 1 | 2021 | 115 | 0.050 |
Why?
| | Early Diagnosis | 1 | 2022 | 230 | 0.050 |
Why?
| | Curriculum | 2 | 2017 | 910 | 0.050 |
Why?
| | Vascular Resistance | 1 | 2021 | 356 | 0.050 |
Why?
| | Acute Disease | 1 | 2022 | 940 | 0.040 |
Why?
| | Equipment Safety | 1 | 2018 | 38 | 0.040 |
Why?
| | Coronary Angiography | 1 | 2020 | 311 | 0.040 |
Why?
| | Computed Tomography Angiography | 1 | 2018 | 81 | 0.040 |
Why?
| | Systems Integration | 1 | 2017 | 42 | 0.040 |
Why?
| | Cardiovascular System | 1 | 2019 | 127 | 0.040 |
Why?
| | Aortic Valve | 1 | 2021 | 401 | 0.040 |
Why?
| | Aged | 3 | 2022 | 19657 | 0.040 |
Why?
| | Acrylamides | 1 | 2017 | 42 | 0.040 |
Why?
| | Aniline Compounds | 1 | 2017 | 71 | 0.040 |
Why?
| | Magnetic Resonance Angiography | 1 | 2018 | 210 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2021 | 1384 | 0.040 |
Why?
| | Hemoperitoneum | 1 | 2016 | 13 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 1868 | 0.040 |
Why?
| | Equipment Design | 1 | 2018 | 519 | 0.040 |
Why?
| | Pregnancy, Ectopic | 1 | 2016 | 53 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2016 | 116 | 0.030 |
Why?
| | Delayed Diagnosis | 1 | 2016 | 79 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2326 | 0.030 |
Why?
| | Program Development | 1 | 2017 | 357 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1489 | 0.030 |
Why?
| | Abdominal Pain | 1 | 2016 | 133 | 0.030 |
Why?
| | Career Choice | 1 | 2017 | 192 | 0.030 |
Why?
| | Spleen | 1 | 2016 | 510 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2017 | 569 | 0.030 |
Why?
| | Program Evaluation | 1 | 2017 | 845 | 0.030 |
Why?
| | Internet | 1 | 2017 | 633 | 0.030 |
Why?
| | Cohort Studies | 1 | 2023 | 5116 | 0.030 |
Why?
| | Quality of Life | 1 | 2023 | 2366 | 0.030 |
Why?
| | Laparoscopy | 1 | 2016 | 417 | 0.030 |
Why?
| | Mutation | 1 | 2022 | 3457 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2021 | 2235 | 0.020 |
Why?
| | Phlebography | 1 | 2010 | 40 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3443 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 6471 | 0.020 |
Why?
| | Thrombectomy | 1 | 2010 | 60 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2010 | 203 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 6561 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2023 | 9342 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3057 | 0.020 |
Why?
| | Reoperation | 1 | 2010 | 557 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2018 | 5255 | 0.020 |
Why?
| | Living Donors | 1 | 2010 | 319 | 0.020 |
Why?
| | Motion Perception | 1 | 2006 | 13 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 9000 | 0.020 |
Why?
| | Stents | 1 | 2010 | 457 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2023 | 12978 | 0.020 |
Why?
| | Posture | 1 | 2005 | 158 | 0.020 |
Why?
| | Child, Preschool | 1 | 2018 | 9491 | 0.020 |
Why?
| | Cues | 1 | 2006 | 297 | 0.020 |
Why?
| | Postural Balance | 1 | 2006 | 184 | 0.020 |
Why?
| | Pregnancy | 1 | 2016 | 5691 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2006 | 683 | 0.010 |
Why?
| | Exercise Test | 1 | 2005 | 551 | 0.010 |
Why?
| | Young Adult | 1 | 2016 | 10793 | 0.010 |
Why?
| | Animals | 1 | 2015 | 33381 | 0.010 |
Why?
|
|
Bang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|